tiprankstipranks
Advertisement
Advertisement
RxSight price target lowered to $6.50 from $8 at BofA
PremiumThe FlyRxSight price target lowered to $6.50 from $8 at BofA
26d ago
RxSight: Alcon Partnership and Margin Improvements Offset Near-Term Sales Shortfall; Buy Rating and $11 Price Target Reiterated
Premium
Ratings
RxSight: Alcon Partnership and Margin Improvements Offset Near-Term Sales Shortfall; Buy Rating and $11 Price Target Reiterated
26d ago
RxSight, Alcon Partner on Light-Adjustable Cataract Lenses
Premium
Company Announcements
RxSight, Alcon Partner on Light-Adjustable Cataract Lenses
27d ago
RxSight Earnings Call Balances Growth With Headwinds
PremiumCompany AnnouncementsRxSight Earnings Call Balances Growth With Headwinds
3M ago
RxSight price target lowered to $11 from $13 at Needham
Premium
The Fly
RxSight price target lowered to $11 from $13 at Needham
3M ago
RxSight reports Q1 adjusted EPS (19c), consensus (15c)
Premium
The Fly
RxSight reports Q1 adjusted EPS (19c), consensus (15c)
3M ago
RxSight price target lowered to $10 from $11 at Piper Sandler
PremiumThe FlyRxSight price target lowered to $10 from $11 at Piper Sandler
5M ago
RxSight price target raised to $9 from $8 at UBS
Premium
The Fly
RxSight price target raised to $9 from $8 at UBS
5M ago
RxSight reports Q4 EPS (3c), consensus (20c)
Premium
The Fly
RxSight reports Q4 EPS (3c), consensus (20c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100